Volume 12; Issue 3

Main
Pharmacogenomics
Volume 12; Issue 3

Pharmacogenomics

Volume 12; Issue 3

1

Gene-wide tagging study of the association between ABCC2, ABCC5 and ABCG2 genetic polymorphisms and multidrug resistance in epilepsy

Kwan, Patrick, Wong, Virginia, Ng, Ping Wing, Lui, Colin Hiu Tung, Sin, Ngai Chuen, Wong, Ka Sing, Baum, Larry

Journal:

Pharmacogenomics

Year:

2011

Language:

english

File:

PDF, 391 KB

english, 2011

2

Association analysis of thromboxane A synthase 1 gene polymorphisms with aspirin intolerance in asthmatic patients

Oh, Sun-Hee, Kim, Yong-Hoon, Park, Se-Min, Cho, Sung-Hwan, Park, Jong-Sook, Jang, An-Soo, Park, Sung-Woo, Uh, Soo-Taek, Lee, Youg-Mok, Kim, Mi-Kyeong, Choi, Inseon S, Cho, Sang Heon, Hong, Chein-Soo,

Journal:

Pharmacogenomics

Year:

2011

Language:

english

File:

PDF, 1.32 MB

english, 2011

3

Use of a comprehensive panel of biomarkers to predict response to a fluorouracil–oxaliplatin regimen in patients with metastatic colorectal cancer

Lamas, Maria J, Duran, Goretti, Balboa, Emilia, Bernardez, Beatriz, Touris, Manuel, Vidal, Yolanda, Gallardo, Elena, Lopez, Rafael, Carracedo, Angel, Barros, Francisco

Journal:

Pharmacogenomics

Year:

2011

Language:

english

File:

PDF, 701 KB

english, 2011

4

Polymorphisms present in G-protein-coupled receptor kinases and their effect on β-blocker treatment

Raake, Philip W, Koch, Walter J, Most, Patrick

Journal:

Pharmacogenomics

Year:

2011

Language:

english

File:

PDF, 660 KB

english, 2011

5

Sieving treatment biomarkers from blood gene-expression profiles: a pharmacogenomic update on two types of multiple sclerosis therapy

Goertsches, Robert H, Zettl, Uwe K, Hecker, Michael

Journal:

Pharmacogenomics

Year:

2011

Language:

english

File:

PDF, 715 KB

english, 2011

6

Clinical and genetic correlates of suicidal ideation during antidepressant treatment in a depressed outpatient sample

Perroud, Nader, Bondolfi, Guido, Uher, Rudolf, Gex-Fabry, Marianne, Aubry, Jean-Michel, Bertschy, Gilles, Malafosse, Alain, Kosel, Markus

Journal:

Pharmacogenomics

Year:

2011

Language:

english

File:

PDF, 1.03 MB

english, 2011

7

Central neurotoxicity in cancer chemotherapy: pharmacogenetic insights

Froklage, Femke EAM, Reijneveld, Jaap C, Heimans, Jan J

Journal:

Pharmacogenomics

Year:

2011

Language:

english

File:

PDF, 750 KB

english, 2011

8

Systems pharmacology assessment of the 5-fluorouracil pathway

Muhale, Filipe A, Wetmore, Barbara A, Thomas, Russell S, McLeod, Howard L

Journal:

Pharmacogenomics

Year:

2011

Language:

english

File:

PDF, 2.13 MB

english, 2011

9

Application of cost–effectiveness analysis to demonstrate the potential value of companion diagnostics in chronic myeloid leukemia

Gaultney, Jennifer G, Sanhueza, Enrique, Janssen, Jeroen J, Redekop, William K, Uyl-de Groot, Carin A

Journal:

Pharmacogenomics

Year:

2011

Language:

english

File:

PDF, 873 KB

english, 2011

10

Research Highlights

LLerena, Adrián, Dorado, Pedro, Peñas-LLedó, Eva M

Journal:

Pharmacogenomics

Year:

2011

Language:

english

File:

PDF, 359 KB

english, 2011

11

Gene copy number variations: it is important to determine which allele is affected

Ramamoorthy, Anuradha, Skaar, Todd C

Journal:

Pharmacogenomics

Year:

2011

Language:

english

File:

PDF, 610 KB

english, 2011

12

Conference Scene: Report on the 8th Annual Cold Spring Harbor/Wellcome Trust meeting on Pharmacogenomics and Personalized Medicine

Carr, Daniel F, Alfirevic, Ana

Journal:

Pharmacogenomics

Year:

2011

Language:

english

File:

PDF, 1.45 MB

english, 2011

13

Identification of predictive markers of cytarabine response in AML by integrative analysis of gene-expression profiles with multiple phenotypes

Lamba, Jatinder K, Crews, Kristine R, Pounds, Stanley B, Cao, Xueyuan, Gandhi, Varsha, Plunkett, William, Razzouk, Bassem I, Lamba, Vishal, Baker, Sharyn D, Raimondi, Susana C, Campana, Dario, Pui, Ch

Journal:

Pharmacogenomics

Year:

2011

Language:

english

File:

PDF, 1.11 MB

english, 2011

14

Letter to the Editor: Does a cost-effective approach for the determination of KRAS mutations maximize the patient’s benefit in a clinical setting?

Kobunai, Takashi, Watanabe, Toshiaki, Yamamoto, Yoko, Fukusato, Toshio

Journal:

Pharmacogenomics

Year:

2011

Language:

english

File:

PDF, 3.38 MB

english, 2011

15

Risk modeling strategies for pharmacogenetic studies

Jorgensen, Andrea L, Pirmohamed, Munir

Journal:

Pharmacogenomics

Year:

2011

Language:

english

File:

PDF, 867 KB

english, 2011

16

Acknowledgements

Journal:

Pharmacogenomics

Year:

2011

Language:

english

File:

PDF, 112 KB

english, 2011

17

News & Views in ... Pharmacogenomics

Journal:

Pharmacogenomics

Year:

2011

Language:

english

File:

PDF, 1.26 MB

english, 2011

18

Letter to the Editor: Reply to Kobunai et al.

Carotenuto, Pietro, Roma, Cristin, Rachiglio, Anna Maria, Normanno, Nicola

Journal:

Pharmacogenomics

Year:

2011

Language:

english

File:

PDF, 3.40 MB

english, 2011